The therapeutic efficacy of Viferon, a recombinant human interferon alpha-2b (rectal suppositoria) was studied in the therapy of relapsing herpesvirus infection in women. The clinical efficacy of the drug was recorded in 90% of the patients. The analysis of the remote results of the treatment made it possible to conclude that the Viferon suppositoria had an antirelapsing activity.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
therapy relapsing
8
relapsing herpesvirus
8
herpesvirus infection
8
[viferon suppositoria
4
suppositoria therapy
4
infection women]
4
women] therapeutic
4
therapeutic efficacy
4
efficacy viferon
4
viferon recombinant
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!